Selective inhibitor of CYP2C9 (Ki = 0.3 &muM) inhibit endothelium-derived hyperpolarizing factor synthase, a CYP450 isozyme in the porcine coronary artery homologous to CYP2C8/9 that generates reactive oxygen species in coronary endothelial cells
Selective inhibitor of CYP2C9 (Ki = 0.3 &muM) inhibit endothelium-derived hyperpolarizing factor synthase, a CYP450 isozyme in the porcine coronary artery homologous to CYP2C8/9 that generates reactive oxygen species in coronary endothelial cells
Selective inhibitor of CYP2C9 (Ki = 0.3 &muM) inhibit endothelium-derived hyperpolarizing factor synthase, a CYP450 isozyme in the porcine coronary artery homologous to CYP2C8/9 that generates reactive oxygen species in coronary endothelial cells
Selective inhibitor of CYP2C9 (Ki = 0.3 &muM) inhibit endothelium-derived hyperpolarizing factor synthase, a CYP450 isozyme in the porcine coronary artery homologous to CYP2C8/9 that generates reactive oxygen species in coronary endothelial cells
The active metabolite of the antiviral prodrug oseltamivir acts as an inhibitor of influenza neuraminidases A and B (IC<sub>50</sub> values are 0.1 to 4.9 nM for both enzymes), in this way preventing virus budding and release.
The active metabolite of the antiviral prodrug oseltamivir acts as an inhibitor of influenza neuraminidases A and B (IC<sub>50</sub> values are 0.1 to 4.9 nM for both enzymes), in this way preventing virus budding and release.